CORDIS - Resultados de investigaciones de la UE
CORDIS

Deconstructing the evolution of metastasis

Descripción del proyecto

Revelación de los aspectos principales del proceso metastásico

La metástasis es un proceso complejo que requiere que las células cancerosas anulen funciones celulares clave y cambien sus interacciones con el sistema inmunitario y el microentorno circundante. A pesar de que la metástasis es una de las características principales del cáncer, su cinética y sus mecanismos reguladores aún no se comprenden bien. El objetivo del proyecto Evomet, financiado con fondos europeos, es analizar la cascada metastásica y su evolución e identificar mecanismos diana para el desarrollo de tratamientos y fármacos. El proyecto también ofrecerá un programa de formación multidisciplinaria para investigadores noveles sobre la metodología de vanguardia y las competencias transferibles para que desarrollen su trayectoria profesional en este campo.

Objetivo

Evomet aims to create a high-level training programme on the various aspects of metastasis evolution in order to provide young researchers with skills to become future leaders in the field. To this end, it is imperative to have a solid mentoring and training strategy, a state-of-the-art scientific approach, and a broad range of complementary soft skills. Collectively, these skills will be provided to each ESR through a series of events (local and network-wide) and initiatives that will allow ESRs to ensure smooth progress of their research projects and a successful career.
Scientifically, Evomet has been designed to address an unmet medical need through leverage of basic science to impact drug development and, ultimately, improve how patients are managed. Scientific WPs tackling metastasis from a functional perspective have been defined. To metastasize, cancer cells must orchestrate diverse cellular functions to overcome the challenges inherent in the metastatic cascade (Cell Fate – WP1). These functions are also highly dependent on the interactions of the metastatic cell with the host immune system and tissue stroma (Environment – WP2). However, the kinetics of metastasis and, in particular, the mechanisms that regulate metastasis latency remain poorly understood (Latency – WP3). Mapping this complexity, examining patterns of clonal evolution, mechanisms of therapy failure, and pathways for expansion is central to defining new targets (Expansion – WP4). In summary, we are facing a fast-growing multidisciplinary area created from the aggregation of different fields that have problems communicating with each other. Evomet’s success builds on the strong relations between partners, the open exchange of ideas, state-of-the-art methodology, tools and equipment as well as the exploitation of synergistic opportunities between the network members, covering different perspectives and filling the gap between them, thus breaking the isolation between disciplines.

Coordinador

FUNDACIO INSTITUT DE RECERCA BIOMEDICA (IRB BARCELONA)
Aportación neta de la UEn
€ 501 809,76
Dirección
CARRER BALDIRI REIXAC 10-12 PARC SCIENTIFIC DE BARCELONA
08028 Barcelona
España

Ver en el mapa

Región
Este Cataluña Barcelona
Tipo de actividad
Research Organisations
Enlaces
Coste total
€ 501 809,76

Participantes (14)